Connect with us

Technology

Medical Writing Market Size Indicating $ 9.09 billion by 2031, Featuring Profiles of Cactus Communications, Certara, Covance, Freyr Solutions, InClin Inc

Published

on

The report from The Insight Partners lists several stakeholders—including pharmaceutical and biotech companies, CROs, regulatory authorities, healthcare providers, and academic institutions—along with valuable insights on navigating the evolving market landscape and unlocking new opportunities successfully.

NEW YORK, Dec. 13, 2024 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, global medical writing market is expected to reach US$ 9.09 billion by 2031 from US$ 3.44 billion in 2021; it is anticipated to record a CAGR of 10.2% during the forecast period. Medical writing is the creation of scientific documents that communicate medical, clinical, and healthcare information clearly and accurately. It involves preparing documents for regulatory submissions, clinical trial protocols, scientific publications, medical device documentation, and educational materials.

The medical writing market is growing owing to the expansion of the pharmaceutical, biotechnology, and medical device industries, along with an increase in clinical trials and drug development. Moreover, the growing emphasis on personalized medicine, stricter regulatory requirements, and globalization of healthcare are expected to favor market growth in the coming years.

Market leaders and key company profiles          

Cactus CommunicationsCertaraCovanceFreyr SolutionsInClin IncParexel International CorporationQuanticateSIRO Clinpharm Private LimitedSynchrogenixTrilogy Writing and Consulting GmbH

Request a Customized Copy of the Medical Writing Market Report @ https://www.theinsightpartners.com/reports/medical-writing-market/

Overview of Report Findings

Expansion of Pharmaceutical and Biotech Industries: As pharmaceutical and biotechnology sectors continue to innovate and develop drugs, therapies, and technologies, the demand for high-quality and precise documentation has surged. The growth is largely attributed to the increasing regulatory requirements, clinical trials, and research outputs that require detailed and well-structured documents such as clinical study reports, regulatory submission documents, and scientific publications. With the rapid development of mRNA vaccines, pharmaceutical companies, such as Pfizer and Moderna, have faced increased needs for medical writing expertise to ensure compliance and accuracy in regulatory filings and publications. Additionally, the increasing number of biotechnology startups has created a greater demand for outsourcing medical writing services to handle complex scientific data effectively. Thus, the expansion of the pharmaceutical and biotechnology industries drives the market.Expansion of Clinical Trials: With the increasing number of global clinical trials, especially in emerging fields such as oncology, rare diseases, and personalized medicines, there is a higher demand for medical writers to prepare essential documents, such as trial protocols, clinical study reports, investigator brochures, and patient consent forms. Additionally, the rise of decentralized and virtual clinical trials increases the complexity of documentation, requiring medical writers to adapt to new formats and regulatory standards. The growing clinical trials presents opportunities for medical writers to support sponsors and contract research organizations in ensuring regulatory compliance, accuracy, and clarity in the documentation of clinical trial data. The expansion of clinical trials provides significant opportunities in the medical writing industry as the need for precise documentation of trial processes and outcomes becomes critical.Geographical Insights: In 2021, North America led the medical writing market with a substantial revenue share, followed by Europe and APAC, respectively. Further, Asia Pacific is expected to register the highest CAGR during the forecast period.

Report Attributes

Details

Market Size in 2021

US$ 3.44 Billion

Market Size by 2031

US$ 9.09 Billion

CAGR

10.2 %

Base Year

2023

Forecast Period

 2024-2031

Historical Data

 2021-2022

Key Regional Coverage

North America (US, Canada, Mexico), Europe – [UK, Germany, France, Russia, Italy, Rest of Europe]

Asia-Pacific – [China, India, Japan, Australia, Rest of Asia-Pacific]

South and Central America [Brazil, Argentina, Rest of South and Central America]

Middle East and Africa [South Africa, Saudi Arabia, UAE and Rest of Middle East and Africa]

 

Market Segmentation

Based on type, the medical writing market is segmented into clinical writing, regulatory writing, and scientific writing. The clinical writing segment held the largest share of the market in 2021.By application, the medical writing market is categorized into medical journalism, medical education, and medico marketing. The medical education segment accounted for the largest share of the market in 2021.In terms of end users, the medical writing market is bifurcated into pharmaceutical and biotechnology companies and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment led the market in 2021.The medical writing market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Segments Covered –

By Type

Clinical WritingRegulatory WritingScientific Writing

By Application

Medical JournalismMedical EducationMedico Marketing

By End User

Pharmaceutical and Biotechnology CompaniesContract Research Organizations

Access PDF Sample Medical Writing Market Report (Including Graphs, Charts & Figures) – https://www.theinsightpartners.com/sample/TIPRE00008502/

Competitive Strategy and Development

Trending Topics: Regulatory writing for gene therapies and mRNA Vaccines, decentralized and virtual clinical trials, patient-centric documentation, and artificial intelligence in medical writing, among others.

Global Headlines on Medical Writing Market 

PPD Completes Evidera Acquisition, Strengthens Leadership in Real-World ResearchCognizant and Yseop Announced a Plan to Partner to Scale Medical Writing through Generative AI

Regional Analysis –

The Asia Pacific medical writing market is expected to reach US$ 983.51million in 2027 from US$ 560.59million in 2019. The market is estimated to grow with a CAGR of 7.3% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as an increased number of market players and an immense government support in the healthcare sector.The North America medical writing market is expected to reach US$ 1,266.23million in 2027 from US$ 732.95million in 2019. The market is estimated to grow with a CAGR of 7.1% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as increased requirement of medical writers due to stringent regulatory framework and robust growth in clinical trials.The Europe medical writing market is expected to reach US$ 1,114.92million in 2027 from US$ 655.84million in 2019. The market is estimated to grow with a CAGR of 6.9% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as an increased number of clinical trials and an immense growth in the medical device industry

Get Flat 30% Discount on purchase of Medical Writing Market Research Report with 10% extra customization: https://www.theinsightpartners.com/buy/TIPRE00008502/

Conclusion

The medical writing market is experiencing robust growth, driven by healthcare advancements, regulatory demands, and the expansion of clinical research. With the increasing complexity of drug development, personalized medicine, and cutting-edge therapies such as gene and cell-based treatments, the demand for highly skilled medical writers is surging. The global expansion of clinical trials, the rise of real-world evidence, and the growing focus on patient-centric documentation are further contributing to new trends in the market. Additionally, the integration of digital health technologies and artificial intelligence is reshaping the way medical writers operate, creating new opportunities for efficiency and innovation. Moreover, as the pharmaceutical and biotech industries continue to evolve, medical writing is anticipated to remain a crucial element in ensuring clarity, accuracy, and regulatory compliance in scientific communication, thereby fueling market expansion.

More Trending Latest Research Life Sciences Research Reports by The Insight Partners –

The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 million in 2022 to US$ 7,00,873.94 million by 2028; it is expected to grow at a CAGR of 13.4% from 2022 to 2028

Pediatric Medical Devices market size is projected to reach US$ 54.87 billion by 2031 from US$ 32.48 billion in 2023. The market is expected to register a CAGR of 6.78% during 2023–2031

Biopharmaceutical Processing Equipment and Consumable Market Size and Forecasts 2021 – 2031

3D Printing Medical Devices Market Size and Growth 2031

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person:
Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Website – https://www.theinsightpartners.com/
Follow Us: LinkedIn | Facebook | Twitter 

Logo: https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/medical-writing-market-size-indicating–9-09-billion-by-2031–featuring-profiles-of-cactus-communications-certara-covance-freyr-solutions-inclin-inc-302331443.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Portland General Electric declares dividend

Published

on

By

PORTLAND, Ore., July 24, 2026 /PRNewswire/ — The board of directors of Portland General Electric Company (NYSE: POR) declared a quarterly common stock dividend of $0.55125 per share.

The company’s dividend is evaluated based on capital requirements and financial performance. PGE targets a dividend payout ratio of 60 to 70% over the long term.

The quarterly dividend is payable on or before October 15, 2026, to shareholders of record at the close of business on September 25, 2026.

About Portland General Electric Company
Portland General Electric (NYSE: POR) is an integrated energy company that generates, transmits and distributes electricity to nearly 960,000 customers serving an area of approximately 2 million Oregonians. Since 1889, Portland General Electric (PGE) has been powering economies, delivering safe, affordable and reliable electricity while working to transform energy systems to meet evolving customer needs. PGE continues to make progress towards emissions reduction targets, and customers have set the standard for prioritizing clean energy with the No. 1 voluntary renewable energy program in the country. PGE is ranked a top ten utility in the 2025 Forrester U.S. Customer Experience Index. In 2025, PGE employees and retirees volunteered over 18,300 hours to more than 400 nonprofits organizations. Through the PGE Foundation, along with corporate contributions and the employee matching gift program, more than $5 million was directed to charitable organizations supporting economic growth and community resilience across our service area. For information: portlandgeneral.com/news.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions about the future, involve risks and uncertainties, and are not guarantees. Future results may differ materially from those expressed or implied in any forward-looking statement. These forward-looking statements represent our estimates and assumptions only as of the date of this press release. We assume no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise.

Forward-looking statements include statements, other than statements of historical or current fact, regarding the Company’s amount and timing of dividends payable as well as other statements containing words such as “committed to,” “targets,” or similar expressions.

There can be no assurance that future dividends will be declared. The declaration of future dividends is subject to approval of our board of directors and various risks and uncertainties, including, but not limited to: our cash flow and cash needs; the timing or amount of dividends paid; the timing or outcome of various legal and regulatory actions; changes in the Company’s business strategy; increases in capital expenditures; changes in capital and credit market conditions, including volatility of equity markets as well as changes in PGE’s credit ratings and outlook on such credit ratings restrictions on the payment of dividends under existing or future financing arrangements; changes in tax laws relating to corporate dividends; deterioration in our financial condition or results, and those risks, uncertainties, and other factors identified from time-to-time in our filings with the United States Securities and Exchange Commission (SEC), including our annual report on Form 10-K for the year ended December 31, 2025 and subsequent quarterly reports on Form 10-Q. These reports are available through the EDGAR system free-of-charge on the SEC’s website, www.sec.gov and on the Company’s website, investors.portlandgeneral.com. Investors should not rely unduly on any forward-looking statements. The Company assumes no obligation to update or revise any forward-looking statement as a result of new information, future events or other factors.

Media Contact:
Drew Hanson
Corporate Communications
Phone: 503-464-2067

Investor Contact:
Erin Schwartz
Investor Relations
Phone: 503-464-7751

View original content:https://www.prnewswire.com/news-releases/portland-general-electric-declares-dividend-302834503.html

SOURCE Portland General Company

Continue Reading

Technology

Care Career Announces Acquisition of MAS Medical Staffing, Completing Its First Acquisition Phase and Expanding Annual Revenue Beyond $150 Million, with a Path to Exceed a Quarter Billion by the End of 2026 Through Additional Acquisitions and Organic Growth

Published

on

By

WOODBRIDGE, N.J., July 24, 2026 /PRNewswire/ — Care Career, a rapidly growing healthcare workforce technology organization, today announced the acquisition of MAS Medical Staffing, one of the Northeast’s leading healthcare workforce organizations. Financial terms of the transaction were not disclosed.

The acquisition represents Care Career’s seventh strategic acquisition in the past 24 months, further strengthening the company’s position as one of the largest healthcare workforce organizations in the United States while accelerating its strategy to redefine the future of healthcare workforce management through artificial intelligence, enterprise technology, and workforce innovation.

MAS Medical Staffing has built an outstanding reputation for delivering high-quality workforce solutions through strong client relationships, exceptional clinician engagement, and deep regional expertise throughout the Northeastern United States. The acquisition significantly expands Care Career’s geographic footprint while broadening its access to healthcare professionals, client relationships, workforce data, and regional market intelligence.

Care Career is building a technology-enabled workforce ecosystem powered by its AI-powered workforce platform, where every acquisition contributes not only additional market presence, but also expanded data, enhanced artificial intelligence capabilities, digital innovation, and operational scale that continuously improve the experience for clients and clinicians alike. As the platform grows, every clinician engagement, client interaction, credential, placement, and workforce trend strengthens the intelligence of Career’s technology, creating a continuously improving ecosystem designed to deliver faster, smarter, and more effective workforce solutions.

The acquisition also brings MAS Medical Staffing’s MAESTRA® engagement technology, along with its client relationships and clinician network, directly onto Career’s AI-powered workforce platform. MAESTRA’s scheduling, credentialing, and communication capabilities will be integrated into Care Career’s existing technology stack, further enhancing clinician engagement across onboarding, scheduling, and career management while providing healthcare organizations with greater workforce visibility and operational efficiency.

“Our vision is to build the AI-powered infrastructure that modernizes healthcare workforce management,” said Siva Konatham, Group President and Chief Executive Officer of Care Career. “Under my leadership, Care Career is focused on transforming a fragmented, labor-intensive industry into a data-driven, technology-enabled ecosystem that improves speed, efficiency, and workforce visibility for healthcare providers. Each acquisition strengthens our platform intelligence, expands our scale, and enhances our margin potential. By integrating advanced analytics, AI automation, and digital engagement tools, we are not just growing revenue—we are building a smarter, more scalable model positioned to lead the next era of healthcare workforce solutions.”

The combined organization will leverage expanded recruiting resources, centralized credentialing, advanced workforce analytics, AI-enabled automation, and digital engagement technologies—all powered by Care Career’s AI-powered workforce platform—to deliver broader recruiting capabilities, faster response times, enhanced workforce insights, and expanded national coverage. Clinicians will benefit from a seamless digital experience that simplifies every stage of their careers—from job discovery and credentialing to onboarding, scheduling, communication, and long-term career development.

With seven strategic acquisitions completed in less than two years, representing the first round of acquisitions now totaling more than $150 million in annual revenue, Care Career has rapidly expanded its national presence while executing a disciplined growth strategy focused on technology integration, operational excellence, and workforce innovation. The company has also signed additional Letters of Intent with other entities with expected close dates in the third quarter of 2026. Upon completion of these transactions, coupled with organic growth, Care Career expects consolidated annual revenue to exceed a quarter of a billion dollars by the end of 2026.

The addition of MAS Medical Staffing further strengthens the organization’s ability to serve healthcare systems, hospitals, long-term care providers, outpatient facilities, and other healthcare organizations across an increasingly diverse geographic footprint.

“The healthcare workforce industry is entering a new era where technology, artificial intelligence, and data-driven decision-making will define the market leaders,” Konatham added. “Every acquisition we complete expands the intelligence of our AI-powered workforce platform, enhances the value we deliver to our clients, and creates more opportunities for clinicians. We believe the combination of exceptional people, innovative technology, and strategic scale positions Care Career to lead the next generation of healthcare workforce solutions.”

About Care Career

Care Career is a technology-enabled healthcare workforce solutions company dedicated to transforming how healthcare organizations recruit, engage, credential, deploy, and retain clinical talent. Powered by its proprietary AI-powered workforce platform and supported by advanced artificial intelligence, enterprise technology, and workforce analytics, Care Career is building an intelligent healthcare workforce ecosystem that connects providers and clinicians more efficiently while improving workforce performance, operational effectiveness, and patient care. Following seven strategic acquisitions over the past 24 months the first round of acquisitions totaling more than $150 million in annual revenue and with additional signed LOIs under contract expected to complete shortly, positioning the company to surpass a quarter of a billion dollars in consolidated annual revenue by the end of 2026, Care Career has become one of the nation’s largest and fastest-growing healthcare workforce organizations, serving healthcare providers and clinicians across the United States.

About MAS Medical Staffing

MAS Medical Staffing is a premier healthcare workforce organization recognized for exceptional service, strong client partnerships, and a commitment to connecting healthcare professionals with rewarding career opportunities. With an established presence throughout the Northeastern United States, MAS Medical Staffing has earned a reputation for quality, responsiveness, and delivering workforce solutions that help healthcare providers meet their evolving workforce needs while supporting clinicians throughout every stage of their careers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/care-career-announces-acquisition-of-mas-medical-staffing-completing-its-first-acquisition-phase-and-expanding-annual-revenue-beyond-150-million-with-a-path-to-exceed-a-quarter-billion-by-the-end-of-2026-through-additional-acqu-302834472.html

SOURCE Care Career

Continue Reading

Technology

PointsKash Demonstrates How Businesses Can Build on Bitcoin Without Burdening the Blockchain

Published

on

By

As industry debate surrounding Bitcoin Improvement Proposal (BIP-110) intensifies, PointsKash unveils an architecture designed to work regardless of the proposal’s outcome.

SCOTTSDALE, Ariz., July 24, 2026 /PRNewswire/ — As the global Bitcoin community debates Bitcoin Improvement Proposal 110 (BIP-110) and the future of data stored on the Bitcoin blockchain, PointsKash, Inc. today announced that its next-generation kiosk infrastructure was intentionally designed to operate efficiently under any outcome of the proposal.

Rather than storing operational data directly on the Bitcoin blockchain, PointsKash utilizes a layered architecture that combines Bitcoin‘s unmatched security with modern decentralized communications technology. Every transaction, machine event, system update, and operational record generated across the PointsKash network is cryptographically verified, securely maintained off-chain, and anchored to the Bitcoin blockchain through a single immutable cryptographic proof.

This approach allows thousands of operational events to be permanently verified while utilizing only a minimal amount of blockchain data.

As discussion surrounding BIP-110 has intensified across the digital asset industry, PointsKash believes the debate does not require choosing between innovation and responsible blockchain stewardship.

“The industry has been debating whether businesses can build meaningful applications on Bitcoin without unnecessarily consuming blockchain space,” said Michael Herron, Chief Executive Officer of PointsKash. “We believe we’ve demonstrated that the answer is yes. Bitcoin provides the world’s most trusted immutable timestamp and security layer, while higher-volume operational data belongs on technologies specifically designed to manage it. By combining both, we’ve built an architecture that is scalable, transparent, and future-ready regardless of how the BIP-110 discussion ultimately evolves.”

The company’s infrastructure assigns every kiosk its own unique cryptographic identity, allowing each machine to securely authenticate every transaction and operational event. Those records are then independently verifiable through cryptographic proofs while remaining resistant to alteration or manipulation—even by PointsKash itself.

According to the company, this architecture delivers several significant advantages:

Mathematically verifiable transaction records for regulators, banking partners, auditors, and enterprise customers.Improved network reliability, allowing kiosks to continue operating during temporary connectivity interruptions without losing transaction history.Enhanced cybersecurity, with every machine maintaining its own authenticated identity and secure communications.A scalable blockchain architecture that minimizes on-chain data while preserving complete auditability.

Bitcoin was created to provide trust, security, and permanence—not to become a storage system for every piece of application data,” Herron added. “Our philosophy has always been simple: use Bitcoin for what it does better than anyone else—creating immutable proof that records have never been altered—and leverage modern decentralized technologies for everything else. We believe that’s the future of enterprise blockchain infrastructure.”

PointsKash believes this architecture positions the company among a new generation of fintech innovators utilizing Bitcoin as a secure trust layer while developing scalable financial applications for enterprise deployment.

The technology also establishes the foundation for future blockchain-based financial products currently under development, including enhanced digital audit capabilities, verifiable financial records, enterprise licensing opportunities, and next-generation digital asset infrastructure.

As the Bitcoin ecosystem continues to mature, PointsKash believes its technology demonstrates that responsible innovation and blockchain scalability can successfully coexist—providing enterprise organizations with the confidence to build on Bitcoin without contributing unnecessary data to the network.

About PointsKash, Inc.

PointsKash, Inc. is a financial technology company developing an integrated ecosystem of AI-enabled self-service financial centers, digital banking, digital payment solutions, cryptocurrency services, loyalty rewards, enterprise merchant technologies, and mobile financial applications. Through proprietary software, Artificial Intelligence, and strategic partnerships, PointsKash is building innovative financial solutions designed to empower consumers, merchants, and enterprise organizations throughout North America.

For more information, visit www.pointskash.com.

Media Contact

PointsKash, Inc.
Investor Relations
info@pointskash.com
www.pointskash.com

Forward-Looking Statements

This press release contains forward-looking statements regarding anticipated technology integrations, Artificial Intelligence initiatives, product development, future commercialization plans, expected operational efficiencies, business strategy, and future growth. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that could affect actual results include, but are not limited to, technology development timelines, integration efforts, financing, regulatory developments, market conditions, and other risks facing the Company. PointsKash undertakes no obligation to update any forward-looking statements except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pointskash-demonstrates-how-businesses-can-build-on-bitcoin-without-burdening-the-blockchain-302834473.html

SOURCE PointsKash Inc.

Continue Reading

Trending